ARCHIVES

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

This article is from The Cancer Letter archive.

Vol. 33 No. 40 | November 2, 2007

Download PDF Visit The Full Archive

Related Articles

Organ Site Grants Fare Badly In NIH Study Section Review; RPMI, UT Galveston, Rush Compete For HQ

October 21, 1983

NCI to Recompete contracts for Frederick

December 4, 1992

NCI To Recomplete Frederick Contract To Start In 1977

October 17, 1975

DCT Board Okays Recompetition of $15 Million In contract Projects

November 10, 1978

In Brief: Everson, Clarke New ACCC Leaders; Katterhagen To Move To Burbank; Vote On Healy Expected

March 22, 1991

NCI T BE More Flexible In Funding RFAs Above Paylines

June 23, 1989